Last updated 2026-07-26
- Raised $8M Series A led by Integra Holdings, Aug 2017
Total raised
$8.0M
Last: Undisclosed Round 2017-09
Stage
Series A
Founded
2005
Headcount
7
HQ
Jerusalem, Israel
Sector
Health Tech & Life Sciences
About
LipoCure is developing highly-potent therapeutics utilizing proprietary liposome-based nano-drugs with novel drug-loading and drug-release mechanisms. Their platform technology enhances drug delivery, improves therapeutic efficacy, and reduces side effects for treatments of inflammatory diseases, infections, and cancers. Founded by Professor Barenholz, co-developer of Doxil®, LipoCure aims to bring more effective and safer therapies through innovative liposomal drug delivery systems. The proprietary platform allows for the remote drug loading into nanoliposomes and enables controlled release of the drugs at the targeted site allowing for enhanced permeability and retention (EPR).
Funding history · 1 round · $8.0M total
2017-08
A Round
$8.0M
★ Integra Holdings★ Yechezkel Barenholz
Headcount over time
From 7 (2018-10) to 7 (2026-07) · +0 (+0%) · 13 points · source: Finder history + radar grounding
Q&A
- What is LipoCure's primary focus?
- LipoCure is developing therapeutics using proprietary liposome-based nano drugs with novel drug-loading and release mechanisms.
- When was LipoCure founded?
- LipoCure was founded in November 2005.
- Where is LipoCure headquartered?
- LipoCure is headquartered in Jerusalem, Jerusalem District, Israel.
- Who is the founder of LipoCure?
- Professor Yechezkel Barenholz is the founder of LipoCure and also serves as its CSO. He is known as the co-developer of Doxil.
- How much funding has LipoCure raised in total?
- LipoCure has raised a total of $8,000,000 USD.
- When was LipoCure's last funding round and who were the investors?
- LipoCure's last funding round occurred in September 2017, with investments from Integra Holdings and Yechezkel Barenholz.
- What is LipoCure's current product stage?
- LipoCure's product is currently in the clinical trial stage.
Team · 1
Yechezkel Barenholz
Founder · Founder
Sectors & technology
Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesPharma & Medical BiotechnologyDrug Delivery
Technologies
Materials & SubstancesNanomaterials
Target customers
Healthcare & Life SciencesLife SciencesPharmaceuticals
Business model
B2B
Highlights
1 Patents
Tags
oncologynanotechnologyinflammatory-diseasespharmaceuticalsmedical-technologiessustained-releaseimmunotherapydrug-deliverypharma-companies
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)
External links
| Website | lipocurerx.com/ |
|---|---|
| linkedin.com/company/3738990 |
Identifiers & details
| Founded | 2005-11 |
|---|---|
| Employees (exact) | 7 |
Radar intelligence
Publications (Crossref)
| Works | 1 |
|---|
Web history (Wayback)
| Domain | lipocurerx.com |
|---|
Certificate / subdomain footprint
| Subdomains | 8 |
|---|
Israeli Companies Registrar (רשם החברות / ICA)
| Registrar # (ח.פ.) | 513757005 |
|---|---|
| Status | פעילה |
| Corp type | ישראלית חברה פרטית |
| Incorporated | 2005-11-30 |
| Purpose | לעסוק בכל עיסוק חוקי |
| Liability | מוגבלת |
| In violation (unfiled) | no |
| Last annual report | 2026 |
| Active charges / liens | 1 |
| Registry events | 2 — charge (1), annual_report (1) |
| Registered address | עין כרם 0 ירושלים |
Recent registry events
| Date | Event |
|---|---|
| 2025-12-24 | רישום שעבוד |
| 2026-02-12 | דו~ח שנתי |